Janus Kinase 2 Determinants for Growth Hormone Receptor Association, Surface Assembly, and Signaling

Molecular Endocrinology

Volumn 17, Issue 11, 2003, Pages 2211-2227

  He, Kai ^a   Wang, Xiangdong ^a   Jiang, Jing ^a   Guan, Ran ^a   Bernstein, Kenneth E ^b   Sayeski, Peter P ^c   Frank, Stuart J ^a,d,e  

^a University of Alabama at Birmingham   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; ENDOGLYCOSIDASE H; GLYCOSIDASE; GROWTH HORMONE RECEPTOR; JANUS KINASE; JANUS KINASE 2; MUTANT PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CELL SURFACE; COMPUTER ANALYSIS; DEGLYCOSYLATION; ENZYME BINDING; ENZYME DEFICIENCY; ENZYME STRUCTURE; FERM DOMAIN; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; CELL LINE, TUMOR; GENE DELETION; HUMANS; JANUS KINASE 2; MACROMOLECULAR SUBSTANCES; MICE; MUTATION; PHOSPHOTYROSINE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RABBITS; RECEPTORS, SOMATOTROPIN; SIGNAL TRANSDUCTION; TRANSFECTION;

JANUS;

EID: 0242267061     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0256     Document Type: Article

References (63)

1. Frank SJ, Messina JL 2002 Growth hormone receptor. In: Oppenheim JJ, Feldman M, eds. Cytokine reference online, 2002. London: Academic Press, Harcourt; website: www.academicpress.com/cytokinereference
2. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537-543
3. Bazan JF 1990 Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934-6938
4. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C 1993 Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244
5. Zhang Y, Jiang J, Kopchick JJ, Frank SJ 1999 Disulfide linkage of growth hormone (GH) receptors (GHR) reflects GH-induced GHR dimerization. Association of JAK2 with the GHR is enhanced by receptor dimerization. J Biol Chem 274:33072-33084
6. Carter-Su C, Schwartz J, Smit LS 1996 Molecular mechanism of growth hormone action. Annu Rev Physiol 58:187-207
7. Carter-Su C, Rui L, Herrington J 2000 Role of the tyrosine kinase JAK2 in signal transduction by growth hormone. Pediatr Nephrol 14:550-557
8. O'Shea JJ, Gadina M, Schreiber RD 2002 Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109(Suppl):S121-S131
9. de Vos AM, Ultsch M, Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312
10. Rowlinson SW, Barnard R., Bastiras S, Robins AJ, Brinkworth R, Waters MJ 1995 A growth hormone agonist produced by targeted mutagenesis at binding site 1. Evidence that site 1 regulates bioactivity. J Biol Chem 270:16833-16839
11. Mellado M, Rodriguez-Frade, JM, Kremer L, von Kobbe C, de Ana AM, Merida I, Martinez-AC 1997 Conformational changes required in the human growth hormone receptor for growth hormone signaling. J Biol Chem 272:9189-9196
12. Rowlinson SW, Behncken SN, Rowland JE, Clarkson RW, Strasburger CJ, Wu Z, Baumbach W, Waters MJ 1998 Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. A specific conformational change may be required for full-length receptor signaling. J Biol Chem 273:5307-5314
13. Gent J, van Kerkhof P, Roza M, Bu G, Strous GJ 2002 Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci USA 99:9858-9863
14. Frank SJ 2002 Receptor dimerization in GH and erythropoietin action: it takes two to tango, but how? Endocrinology 143:2-10
15. Zhu T, Goh ELK, Graichen R, Ling L, Lobie PE 2001 Signal transduction via the growth hormone receptor. Cell Signalling 13:599-616
16. Frank SJ, Gilliland G, Kraft AS, Arnold CS 1994 Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology 135:2228-2239
17. Sotiropoulos A, Perrot-Applanat M, Dinerstein H, Pallier A, Postel-Vinay M-C, Finidori J, Kelly PA 1994 Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription. Endocrinology 135:1292-1298
18. VanderKuur JA, Wang X, Zhang L, Campbell GS, Allevato G, Billestrup N, Norstedt G, Carter-Su C 1994 Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase. J Biol Chem 269:21709-21717
19. Dinerstein H, Lago F, Goujon L, Ferrag F, Esposito N, Finidori J, Kelly PA, Postel-Vinay MC 1995 The proline-rich region of the GH receptor is essential for JAK2 phosphorylation, activation of cell proliferation, and gene transcription. Mol Endocrinol 9:1701-1707
20. Frank SJ, Yi W, Zhao Y, Goldsmith JF, Gilliland G, Jiang J, Sakai I, Kraft A S 1995 Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J Biol Chem 270:14776-14785
21. Tanner JW, Chen W, Young RL, Longmore GD, Shaw AS 1995 The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J Biol Chem 270:6523-6530
22. Chishti AH, Kim AC, Marfatia SM, Lutchman M, Hanspal M, Jindal H, Liu C-S, Low PS, Rouleau GA, Mohandas N, Chasis JA, Conboy JG, Gascard P, Takakuwa Y, Huang S-C, Benz EJ, Bretscher A, Fehon RG, Gusella JF, Ramesh V, Solomon F, Marchesi VT, Tsukita S, Tsukita S, Arpin M, Louvard D, Tonks NK, Anderson JM, Fanning AS, Bryant PJ, Woods D, Hoover KB 1998 The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci 23:281-282
23. Girault J-A, Labesse G, Mornon J-P, Callebaut I 1999 The N-termini of FAK and JAKs contain divergent band 4.1 domains. Trends Biochem Sci 24:54-57
24. Arpin M, Algrain M, Louvard D 1994 Membrane actin microfilament connections: an increasing diversity of players related to band 4.1. Curr Opin Cell Biol 6:136-141
25. Hilkens CM, Is'harc H, Lillemeier BF, Strobl B, Bates PA, Behrmann I, Kerr IM 2001 A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130. FEBS Lett 505:87-91
26. Haan C, Is'harc H, Hermanns HM, Schmitz-Van De Leur H, Kerr IM, Heinrich PC, Grotzinger J, Behrmann I 2002 Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction. J Biol Chem 276:37451-37458
27. Huang LJ, Constantinescu SN, Lodish HF 2001 The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell 8:1327-1338
28. Zhou YJ, Chen M, Cusack NA, Kimmel LH, Magnuson KS, Boyd JG, Lin W, Roberts JL, Lengi A, Buckley RH, Geahlen RL, Candotti F, Gadina M, Changelian PS, O'Shea JJ 2001 Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. Mol Cell 8:959-969
29. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE 1995 Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375:247-250
30. Ali MS, Sayeski PP, Safavi A, Lyles M, Bernstein KE 1998 Janus kinase 3 (Jak2) must be catalytically active to associate with the AT1 receptor in response to angiotensin II. Biochem Biophys Res Commun 249:672-677
31. Sayeski PP, Ali MS, Frank SJ, Bernstein KE 2001 The angiotensin II-dependent nuclear translocation of Stat1 is mediated by the Jak2 protein motif 231YRFRR. J Biol Chem 276:10556-10563
32. Usacheva A, Kotenko S, Witte MM, Colamonici O 2002 Two distinct domains within the N-terminal region of Janus kinase 1 interact with cytokine receptors. J Immunol 169:1302-1308
33. Radtke S, Hermanns HM, Haan C, Schmitz-Van De Leur H, Gascan H, Heinrich PC, Behrmann I 2002 Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression. J Biol Chem 277:11297-11305
34. Ragimbeau J, Dondi E, Alcover A, Eid P, Uze G, Pellegrini S 2003 The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J 22:537-547
35. c and Jak3 double-deficient mice. Int Immunol 12:123-132
36. Kohlhuber F, Rogers NC, Watling D, Feng J, Guschin D, Briscoe J, Witthuhn BA, Kotenko SV, Pestka S, Stark GR, Ihle JN, Kerr IM 1997 A JAK1/JAK2 chimera can sustain α and γ interferon responses. Mol Cell Biol 17:695-706
37. Wang X, He K, Gerhart M, Huang Y, Jiang J, Paxton RL, Yang S, Lu C, Menon RK, Black RA, Baumann G, Frank SJ 2002 Metalloprotease-mediated GH receptor proteolysis and GHBP shedding: determination of extracellular domain stem region cleavage site. J Biol Chem 27752:50510-50519
38. Zhang Y, Guan R, Jiang J, Kopchick JJ, Black RA, Baumann G, Frank SJ 2001 Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis. J Biol Chem 276:24565-24573
39. Yi W, Kim S-O, Jiang J, Park SH, Kraft AS, Waxman DJ, Frank SJ 1996 Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of STAT5b and STAT3 by activated JAK2 kinase. Mol Endocrinol 10:1425-1443
40. Sotiropoulos A, Goujon L, Simonin G, Kelly PA, Postel-Vinay MC, Finidori J 1993 Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor. Endocrinology 132:1863-1865
41. Lobie PE, Wood TJJ, Chen CM, Waters MJ, Norstedt G 1994 Nuclear translocation and anchorage of the growth hormone receptor. J Biol Chem 269:31735-31746
42. Jiang J, Liang L, Kim S-O, Zhang Y, Mandler R, Frank SJ 1998 Growth hormone-dependent tyrosine phosphorylation of a GH receptor-associated high molecular weight protein immunologically related to JAK2. Biochem Biophys Res Commun 253:774-779
43. c chain. J Biol Chem 270:13814-13818
44. Kim S-O, Jiang J, Yi W, Feng G-S, Frank SJ 1998 Involvement of the SH2-containing tyrosine phosphatase SHP-2 in growth hormone signalling. J Biol Chem 273:2344-2354
45. Frank SJ, Gilliland G, Van Epps C 1994 Treatment of IM-9 cells with human growth hormone (GH) promotes rapid disulfide linkage of the GH receptor. Endocrinology 135:148-156
46. Benbassat C, Shoba LNN, Newman M, Adamo ML, Frank SJ, Lowe WL 1999 Growth hormone-mediated regulation of insulin-like growth factor I promoter activity in C6 glioma cells. Endocrinology 140:3073-3081
47. Kim S-O, Loesch K, Wang X, Jiang J, Mei L, Cunnick J, Wu J, Frank SJ 2002 A role for Grb2-associated binder (Gab)-1 in growth hormone signaling. Endocrinology 143:4856-4867
48. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN 1993 Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 90:8429-8433
49. Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J, Carter-Su C 1996 The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol Endocrinol 10:519-533
50. Giordanetto F, Kroemer RT 2002 Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7. Protein Engin 15:727-737
51. Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK, Wilson IA 1999 Cristallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283:987-990
52. Remy I, Wilson IA, Michnick SW 1999 Erythropoietin receptor activation by a ligand-induced conformational change. Science 283:990-993
53. Krause CD, Mei E, Xie J, Jia Y, Bopp MA, Hochstrasser RM, Pestka S 2002 Seeing the light: preassembly and ligand-induced changes of the interferon γ receptor complex in cells. Mol Cell Proteomics 1:805-815
54. Krause CD, Xie J, Mei E, Hochstrasser RM, Pestka S 2002 Probing interactions among cytokine receptor chains with fluorescence resonance energy transfer. J Interferon Cytokine Res 22(Suppl 93):1-10
55. Varghese JN, Moritz RL, Lou MZ, Van Donkelaar A, Ji H, Ivancic N, Branson KM, Hall NE, Simpson RJ 2002 Structure of the extracellular domains of the human interleukin-6 receptor α-chain. Proc Natl Acad Sci USA 99:15959-15964
56. Schuster B, Meinert W, Rose-John S, Kallen K-J 2003 The human interleukin-6 (IL-6) receptor exists as a preformed dimer in the plasma membrane. FEBS Lett 538:113-116
57. Constantinescu SN, Huang LJ-S, Nam H-S, Lodish HF 2001 The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. Mol Cell 7:377-385
58. Greiser JS, Stross C, Heinrich PC, Behrmann I, Hermanns HM 2002 Orientational constraints of the gp130 intracellular juxtamembrane domain for signaling. J Biol Chem 277:26959-26965
59. Saharinen P, Takaluom K, Silvennoinen O 2000 Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol Cell Biol 20:3387-3395
60. Saharainen P, Silvennoinen O 2002 The Pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction. J Biol Chem 277:47954-47963
61. Saharinen P, Vihinen M, Silvennoinen O 2003 Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain. Mol Biol Cell 14:1448-1459
62. Lindauer K, Loerting T, Liedl KR, Kroemer RT 2001 Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation. Protein Engin 14:27-37
63. Mui AL-F, Wakao H, O'Farrell A-M, Harada N, Miyajima A 1995 Interleukin-3, granulocyte-macrophage colony stimulation factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J 14:1166-I 175